CSLP43

CSLP43 is a selective RIPK2 and XIAP inhibitor with an IC50 of 19.9 nM against human RIPK2. CSLP43 binds to the ATP-binding pocket of RIPK2 and disrupts the interaction between RIPK2 and the BIR2 domain of XIAP or cIAP1. CSLP43 inhibits RIPK2 ubiquitination, NOD1-dependent inflammatory signaling pathways, NOD2-dependent inflammatory signaling pathways, as well as NF-κB activation associated with NOD agonists. CSLP43 is selective for the NOD1/NOD2 signaling pathway and does not inhibit the kinase activity of RIPK1 or RIPK3. CSLP43 is applicable to research related to Crohn's disease, Blau syndrome, early-onset sarcoidosis and early-onset inflammatory bowel disease.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • No. CAS: 2244988-80-3
  • Fòrmula: C26H33N5O4S
  • Peso molecular:511.64
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Ver todos los productos específicos de isoformas RIP kinase

More

Ver todos los productos específicos de isoformas IAP

More

Ver todos los productos específicos de isoformas NOD-like Receptor (NLR)

More
100 mg

Obtener un presupuesto En stock

Please select quantity
Amount: USD 0.00